With European Parliament elections next week, and a new Commission in the Autumn, it is vital that policymakers are allowed to focus on what is really important: finding ways to build a true European digital innovation ecosystem
Executives at some of the country's leading domestic mobile manufacturers open up about the reasons they believe an anti-trust investigation of the Swedish company is merited
As this disruptive technology attracts increasing interest, key issuing authorities are developing different ways of handling applications that read on it
A surprise inspection at the Swedish giant’s Beijing office sets the stage for the first big IP probe by China’s new super-regulator
Attorneys say agency’s president has no legal basis for asking the Enlarged Board of Appeal to review the finding that plants produced by biological processes are patentable.
The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals
Judges rule that inventions arrived at by well-established or routine tests can be patented, but the decision will also reassure generics
With so many issues emerging across the entire supply chain, the sector’s IP leaders will be sharing their thoughts and insights at events in Detroit and Munich next month
Following the court’s Abraxis decision, life sciences face a more restrictive interpretation of which products qualify for supplementary protection certificates.
The controversial legislation is set to come into force this year and will place extra burdens on service providers, while heralding a new, more interventionist approach to the regulation of online platforms in the digital economy
Patent focus has shifted to energy storage as cost-effectiveness achieved for wind and solar power, but the failure to address the role of IP hinders transfer mechanisms
The Barcelona Commercial Court saw a 43% jump in its special IP docket during February's gathering of the mobile industry's elite in the Catalan capital, with companies such as Samsung, Xiaomi, ZTE, LG and Sisvel all involved
IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy
Swedish company issues statement after an unsourced Chinese media article claims that a probe into its licensing practices is underway
When it comes to litigation strategy, drug businesses have another option to consider in some cases thanks to recent rulings from the courts of England and Wales.